ArticleCureus2025
When Sutures Fail: Extrusion of an Inspire Device and a Hip Prosthesis in the Same Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implant extrusion is a rare but serious complication typically linked to infection, poor wound healing, or material intolerance. This case report describes a 79-year-old female patient who experienced extrusion of both a hip prosthesis and an Inspire hypoglossal nerve stimulator (Inspire Medical Systems, Inc., Minnesota, USA), each event associated with the use of Ethibond (Ethicon, Johnson & Johnson, Georgia, USA) sutures. The patient had a history of obstructive sleep apnea refractory to continuous positive airway pressure (CPAP) therapy and underwent Inspire device implantation. Postoperatively, she developed a sterile fluid collection and wound dehiscence, leading to visible extrusion of the device. Notably, she had previously experienced a near extrusion of a hip prosthesis, also linked to Ethibond. In both cases, the infectious workup was negative. Following explantation and reimplantation of the Inspire device using Monocryl and Prolene sutures (both by Ethicon, Johnson & Johnson, Georgia, USA) and the application of a dermal graft, the patient achieved successful healing without recurrence. This case underscores the importance of considering suture-related foreign body reactions in patients with recurrent implant extrusion and no evidence of infection. Surgeons should remain vigilant in selecting suture materials, especially in patients with a history of adverse reactions, and future research should explore suture-tissue interactions to guide safer implant practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.